Type 2 Diabetes Mellitus: A Possible Surgically Reversible Intestinal Dysfunction

Imagem de Miniatura
Arquivos
art_SALA_Type_2_Diabetes_Mellitus_A_Possible_Surgically_Reversible_2012.PDF (277.27 KB)
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
HEYMSFIELD, Steven B.
Citação
OBESITY SURGERY, v.22, n.1, p.167-176, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Type 2 diabetes mellitus (T2DM) is a global public health problem often associated with obesity. Bariatric surgery is effective for treating serious obesity, and techniques involving intestinal bypass have metabolic benefits, such as complete and early remission of T2DM. We present a literature review of the possible mechanisms of early normalization of glycemic homeostasis after bariatric surgery, including intestinal gluconeogenesis, increased antidiabetogenic signals from L cells located in the distal small intestine, and impaired secretion of diabetogenic signals in the upper part of the small intestine. Adding to these potential mechanisms, unknown factors that regulate insulin sensitivity may be involved and altered by bariatric surgery. This review discusses the various hypotheses about the mechanisms of glycemic control after bariatric surgery involving intestinal bypass. Further research is essential to better understand these mechanisms and to identify potential new mechanisms that might help in developing less invasive and safer alternatives for the treatment of T2DM and reveal novel pharmaceutical targets for glycemic control.
Palavras-chave
Type 2 diabetes, Small intestine
URI
https://observatorio.fm.usp.br/handle/OPI/642
Referências
  1. Ahren B, 2000, J CLIN ENDOCR METAB, V85, P1043, DOI 10.1210/jc.85.3.1043
  2. American Diabetes Association, 2009, DIABETES CARE, V32, P13
  3. Aronoff S.L, 2004, DIABETES SPECTRUM, V17, P183, DOI 10.2337/diaspect.17.3.183
  4. Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054
  5. Baltasar A, 2005, OBES SURG, V15, P1124, DOI 10.1381/0960892055002248
  6. Battezzati A, 2004, AM J PHYSIOL-ENDOC M, V286, pE124
  7. Bikman BT, 2008, J CLIN ENDOCR METAB, V93, P4656, DOI 10.1210/jc.2008-1030
  8. Bottino R, 2005, DIABETES, V54, P79
  9. Briatore L, 2008, OBESITY, V16, P77, DOI 10.1038/oby.2007.9
  10. Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724
  11. Buchwald H, 2009, OBES SURG, V19, P1605, DOI 10.1007/s11695-009-0014-5
  12. Canadian Diabetes Association, 2008, CLIN PRACT GUID PREV, P77
  13. Chan JL, 2006, OBESITY, V14, P194, DOI 10.1038/oby.2006.25
  14. Chatelain F, 1998, DIABETES, V47, P882, DOI 10.2337/diabetes.47.6.882
  15. Chevallier JM, 2010, J VISC SURG, V147, pE21, DOI 10.1016/j.jviscsurg.2010.08.009
  16. Crookes PE, 2006, ANNU REV MED, V57, P243, DOI 10.1146/annurev.med.56.062904.144928
  17. Cui XL, 2004, PHYSIOL GENOMICS, V18, P206, DOI 10.1152/physiolgenomics.00056.2004
  18. Cummings DE, 2005, CURR DRUG TARGETS, V6, P153
  19. Cummings DE, 2004, J CLIN ENDOCR METAB, V89, P2608, DOI 10.1210/jc.2004-0433
  20. Cummings DE, 2009, INT J OBES LOND, V33, P33
  21. Delaere F, 2010, DIABETES METAB, V36, P257, DOI 10.1016/j.diabet.2010.05.001
  22. Dixon JB, 2009, WORLD J SURG, V33, P2014, DOI 10.1007/s00268-009-0062-y
  23. Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316
  24. Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076
  25. Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004
  26. Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306
  27. FLATT PR, 2007, DIABETES VASC DIS RE, V4, P150
  28. GRIFFEN WO, 1983, SURG GYNECOL OBSTET, V157, P301
  29. Guidone C, 2006, DIABETES, V55, P2025, DOI 10.2337/db06-0068
  30. Gumbiner B, J CLIN ENDOCRINOL ME, V81, P2061
  31. Hall TC, 2010, OBES SURG, V20, P1245, DOI 10.1007/s11695-010-0198-8
  32. Hess DS, 1998, OBES SURG, V8, P267, DOI 10.1381/096089298765554476
  33. HOLST JJ, 1978, DIGESTION, V17, P168
  34. HOLST JJ, 1983, DIABETOLOGIA, V25, P396, DOI 10.1007/BF00282517
  35. Karra E, 2010, TRENDS ENDOCRIN MET, V21, P337, DOI 10.1016/j.tem.2010.01.006
  36. Kashyap SR, 2010, CLEV CLIN J MED, V77, P468, DOI 10.3949/ccjm.77a.09135
  37. Kashyap SR, 2010, INT J OBESITY, V34, P462, DOI 10.1038/ijo.2009.254
  38. Kirchner S, 2005, COMP BIOCHEM PHYS B, V140, P333, DOI 10.1016/j.cbpc.2004.10.019
  39. Knop FK, 2009, DIABETOLOGIA, V52, P2270, DOI 10.1007/s00125-009-1511-8
  40. Korner J, 2005, J CLIN ENDOCR METAB, V90, P359, DOI 10.1210/jc.2004-1076
  41. KREMEN AJ, 1954, ANN SURG, V140, P439, DOI 10.1097/00000658-195409000-00018
  42. Kuntz Emmanuelle, 2004, JOP, V5, P464
  43. Laferrere B, 2010, J CLIN ENDOCR METAB, V95, P4072, DOI 10.1210/jc.2009-2767
  44. Maida A, 2008, ENDOCRINOLOGY, V149, P5670, DOI 10.1210/en.2008-0336
  45. Mari A, 2006, DIABETOLOGIA, V49, P2136, DOI 10.1007/s00125-006-0337-x
  46. Masharami U, 2006, ENDOCRINOLOGIA BASIC, P541
  47. Mason EE, 1998, WORLD J SURG, V22, P919
  48. Meier JJ, 2003, DIABETOLOGIA, V46, P798, DOI 10.1007/s00125-003-1103-y
  49. Mingrone G, 2009, DIABETES METAB, V35, P518, DOI 10.1016/S1262-3636(09)73459-7
  50. Mithieux G, 2009, NUTRITION, V25, P881, DOI 10.1016/j.nut.2009.06.010
  51. Mithieux G, 2005, CURR OPIN CLIN NUTR, V8, P445, DOI 10.1097/01.mco.0000172587.17385.aa
  52. MOJSOV S, 1986, J BIOL CHEM, V261, P1880
  53. NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186
  54. NOVAK U, 1987, EUR J BIOCHEM, V164, P553, DOI 10.1111/j.1432-1033.1987.tb11162.x
  55. Ohneda A, METABOLISM, V44, P47
  56. ORSKOV C, 1986, ENDOCRINOLOGY, V119, P1467
  57. ORSKOV C, 1992, J CLIN ENDOCR METAB, V74, P379, DOI 10.1210/jc.74.2.379
  58. ORSKOV C, 1987, DIABETOLOGIA, V30, P874
  59. ORSKOV C, 1989, J BIOL CHEM, V264, P12826
  60. Parikh M, 2006, Surg Obes Relat Dis, V2, P518, DOI 10.1016/j.soard.2006.07.005
  61. Patriti A, 2007, SURGERY, V142, P74, DOI 10.1016/j.surg.2007.03.001
  62. Patriti A, 2005, OBES SURG, V15, P1258, DOI 10.1381/096089205774512573
  63. POLONSKY KS, 1994, DIABETES, V43, P871, DOI 10.2337/diabetes.43.7.871
  64. Pories W, 2008, J CLIN ENDOCR METAB, V93, P89
  65. PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011
  66. PORIES WJ, 1987, ANN SURG, V206, P316, DOI 10.1097/00000658-198709000-00009
  67. Rehfeld JF, PHYSL REV, V78, P1087
  68. Rodriguez-Grunert L, 2008, OBES REL DIS, V4, P55, DOI 10.1016/J.S0ARD.2007.07.012
  69. Rubino F, 2008, DIABETES CARE, V3, P290
  70. Rubino F, 2004, ANN SURG, V240, P236, DOI 10.1097/01.sla.0000133117.12646.48
  71. Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148
  72. Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b
  73. Rubino FA, 2004, ANN SURG, V239, P1, DOI 10.1097/01.sla.0000102989.54824.fc
  74. Salinari S, 2009, DIABETES CARE, V32, P375, DOI 10.2337/dc08-1314
  75. Sartorelli D.S., 2003, CAD SAUDE PUBLICA S1, V19, P29, DOI 10.1590/S0102-311X2003000700004
  76. Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b
  77. Scheen AJ, 2009, DIABETES METAB, V35, P537, DOI 10.1016/S1262-3636(09)73463-9
  78. Scopinaro N, 2005, DIABETES CARE, V28, P2406, DOI 10.2337/diacare.28.10.2406
  79. Scopinaro N, 1996, SURGERY, V119, P261, DOI 10.1016/S0039-6060(96)80111-5
  80. Service GJ, 2005, NEW ENGL J MED, V353, P249, DOI 10.1056/NEJMoa043690
  81. Shafrir E, 1996, DIABETES METAB, V22, P122
  82. She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649
  83. Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583
  84. Sinclair EM, 2005, PHYSIOLOGY, V20, P357, DOI 10.1152/physiol.00030.2005
  85. Strader AD, 2005, AM J PHYSIOL-ENDOC M, V288, pE447, DOI 10.1152/ajpendo.00153.2004
  86. Sugerman HJ, 2003, ANN SURG, V237, P751, DOI 10.1097/00000658-200306000-00002
  87. Tarnoff M, 2008, DIABETES, V57, pA32
  88. THIM L, 1981, REGUL PEPTIDES, V2, P139, DOI 10.1016/0167-0115(81)90007-0
  89. Thomas S, 2010, NUTR CLIN PRACT, V25, P175, DOI 10.1177/0884533610361739
  90. Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717
  91. Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008
  92. van den Hoek AM, 2004, DIABETES, V53, P1949, DOI 10.2337/diabetes.53.8.1949
  93. Vilsboll T, 2004, DAN MED BULL, V51, P364
  94. Wickremesekera K, 2005, OBES SURG, V15, P474, DOI 10.1381/0960892053723402
  95. Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
  96. Wilson JB, 2010, INSULIN, V5, P46
  97. World Health Organization, 2006, FACTS SHEET DIAB OB
  98. Yanez AJ, 2003, J CELL PHYSIOL, V197, P189, DOI 10.1002/jcp.10337

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/35